Toolkit/novel positron emission tomography ligands

novel positron emission tomography ligands

Assay Method·Research·Since 2020

Also known as: novel PET ligands

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Novel positron emission tomography ligands are presented as an emerging imaging innovation in epilepsy management.

Usefulness & Problems

Why this is useful

Novel positron emission tomography ligands are presented as an emerging imaging innovation in epilepsy management.; PET-based evaluation in epilepsy management

Source:

Novel positron emission tomography ligands are presented as an emerging imaging innovation in epilepsy management.

Source:

PET-based evaluation in epilepsy management

Problem solved

They are included among technologies intended to improve diagnostic and treatment selection capabilities in epilepsy surgery.; expands diagnostic tools for surgical approaches to epilepsy

Source:

They are included among technologies intended to improve diagnostic and treatment selection capabilities in epilepsy surgery.

Source:

expands diagnostic tools for surgical approaches to epilepsy

Problem links

expands diagnostic tools for surgical approaches to epilepsy

Literature

They are included among technologies intended to improve diagnostic and treatment selection capabilities in epilepsy surgery.

Source:

They are included among technologies intended to improve diagnostic and treatment selection capabilities in epilepsy surgery.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

diagnosticrecombination

Input: Chemical

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

Their use requires a PET imaging setting, but the abstract does not specify particular ligands.; requires positron emission tomography imaging context

The abstract does not specify which ligand classes are emphasized or what exact diagnostic gap each ligand addresses.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1diagnostic and treatment limitationssupports2020Source 1needs review

Technical limitations and clinical challenges have historically limited diagnostic tools and treatment methods for surgical management of epilepsy.

Technical limitations and clinical challenges have historically limited the diagnostic tools and treatment methods available for surgical approaches to the management of epilepsy.
Claim 2review scope summarysupports2020Source 1needs review

Recent technological innovations in neurosurgical epilepsy management hold significant promise for improving outcomes and decreasing morbidity.

recent technological innovations in several areas hold significant promise in improving outcomes and decreasing morbidity

Approval Evidence

1 source2 linked approval claimsfirst-pass slug novel-positron-emission-tomography-ligands
novel positron emission tomography ligands

Source:

diagnostic and treatment limitationssupports

Technical limitations and clinical challenges have historically limited diagnostic tools and treatment methods for surgical management of epilepsy.

Technical limitations and clinical challenges have historically limited the diagnostic tools and treatment methods available for surgical approaches to the management of epilepsy.

Source:

review scope summarysupports

Recent technological innovations in neurosurgical epilepsy management hold significant promise for improving outcomes and decreasing morbidity.

recent technological innovations in several areas hold significant promise in improving outcomes and decreasing morbidity

Source:

Comparisons

Source-backed strengths

identified as an innovation area in the review

Source:

identified as an innovation area in the review

novel positron emission tomography ligands and cell-free systems-based high-throughput screening address a similar problem space because they share diagnostic, recombination.

Shared frame: same top-level item type; shared target processes: diagnostic, recombination; same primary input modality: chemical

Compared with ProKAS

novel positron emission tomography ligands and ProKAS address a similar problem space because they share recombination.

Shared frame: same top-level item type; shared target processes: recombination; same primary input modality: chemical

novel positron emission tomography ligands and split-protein complementation assays address a similar problem space because they share diagnostic, recombination.

Shared frame: same top-level item type; shared target processes: diagnostic, recombination; same primary input modality: chemical

Ranked Citations

  1. 1.
    StructuralSource 1World Neurosurgery2020Claim 1Claim 2

    Seeded from load plan for claim cl1. Extracted from this source document.